Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good post Cosa
Hysterical!, good post Jess
Hitting these numbers with everything that’s going on and with an extremely small, limited experienced sales staff, and a relatively small, unknown company speaks volumes . We’re primed for a BO, can you imagine the sales revenue from a big Pharma company?
For the people who were smart enough to load up on this when it hit 4.07, we’ve almost doubled our position…this is great news!
…I can’t believe how many of you are replying to the dude in the basement that keeps misquoting his “wife”
After factoring out his time posting on this board, he netted about 3 cents an hour.Ha!
Absolutely
They’re live now
Cosa, Cosa, Cosa…..wake up buddy, it’s going to take a while, but there is still huge potential here.the sellers bailed because they wanted a quick flip with an eminently high return, selling at 5 bucks isn’t the answer. ….if anything it’s a buy here.
Amen Benny!
Initially, but just pushed it off to the 3rd.
Double digits by 11-1
Absolutely
I think Cervelo will love statement about Peter
…..Im guessing it probably went something like this:
Neil and Robert - “ we want massive salaries, pensions, stock options abound and free reign to come and go as we please”!
Potential suitor “ No”
Neil and Robert- “ Peter let us do whatever we wanted and gave us insurmountable amounts of cash, ridiculously lucrative stock options and autonomy to run the show”
Potential suitor “ that's why AUPH’s stock value has plummeted “
Neil and Robert “ if you don’t honor our demands, we’re outta here”!
Potential Suitor “ bye bye
These are the two most likely peeps to go in a BO.
The likes of a GSK or BMY would have no use for these dudes and their massive salaries when they already have their own.
Saud, I think we’ll see a steady uptick with Q3 earnings on the 1st of November
Spot on Cosa
Excellent point Cosa, could not agree more
This is big news, oddly quiet on the trading side though.
You have a NICE graph Jess!
Good stuff Greg
For a newbie, you got horse sense !
So true Jess!
Honey, I’m home …
https://images.app.goo.gl/nhN1nopXbb56AgpAA
AND….he’s still quoting his make believe “Wife”….who is this clown, hilarious, what a Fudster!
My AUPH notifications are blowing up!
This is porn for big Pharma companies looking to expand their pipeline
A BO, without a doubt and when we all least expect it.I believe $35 was on the table when AUPH dispelled the rumor and PG is trying to position the price north.
Nice moose
AUPH up 2 Mil over estimates for the quarter, pretty damn good in this environment. This type of exposure is needed.Who was that Fudster that kept saying sales were going to decline?
This puts a lot into perspective, any good news on sales, would be a game changer.
The shares of Canadian biotech Aurinia Pharmaceuticals (NASDAQ:AUPH) are trading lower in the morning hours Thursday after RBC Capital Markets lowered its price target, citing Omicron-driven impact for sales of the company’s lupus nephritis therapy, Lupkynis.
Ahead of Aurinia’s (AUPH) quarterly results expected in first half of May, the analysts led by Douglas Miehm set their 1Q and 2022 revenue estimates below the consensus.
The analysts cite the COVID-led impact on Lupkynis sales ramp up due to the spread of Omicron variant largely during 1Q 2022.
“We expect the Omicron wave in Q1/22 to have resulted in lower patient additions vs. discontinuations and drop-offs resulting in a sequential decline in revenues,” they noted, lowering the price target to $22 from $27 per share.
However, the firm maintains the Outperform rating on the stock.
Exactly, WORSE case scenario now is a quick, low BO at $35……you’d have to be an idiot to sell at these levels. Earnings next Wednesday, the stock will jump back into the mid teens.Who thinks the lawsuits have any tread and a BO would make the lawsuits disappear.
Still here , still long, just a matter of time….can’t believe BR and What ( 2 people with no position) are still posting more than investors.
I couldn’t agree more
Personally I think he’s in a holding pattern until some good news comes a long, he’s been quiet on the SRNE board also.
I don’t follow him, but happen to own both of these stocks, my position in AUPH IS MUCH LARGER than my position in SRNE.
Good find dude
I 2nd that
This clown is still quoting his “wife”, what a tool, hilarious!,
That would be smart Moose